Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. - Wikidata - awgldk - TriplyDB

Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

http://www.wikidata.org/entity/Q33630579

about

Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014).

P2860

Q34394167-4AC1BAF9-C50C-4B92-9309-4E9E49A2EC70 Q38260066-E4944806-AC35-4A98-B5EA-18F7B5FAC8C9

P2860

Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

http://www.wikidata.org/entity/Q33630579

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@ast

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@en

type

label

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@ast

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@en

prefLabel

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@ast

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@en

P1433

Q33630579-0C222620-6569-4652-A072-FF9FA3E8C0B3

P1476

Q33630579-14CCE733-17F4-4A61-A2FE-E587D079C414

P2093

Q33630579-04AF4D0A-80DB-438D-A7FC-AC77B2B24195

Q33630579-0DFAC65F-3A01-48A9-8107-398B63CD8BA9

Q33630579-13ADBF03-BBC2-4326-ABF9-644C1E0AA5AE

Q33630579-165758A3-D9B4-422F-BCB5-72C6CDD331AB

Q33630579-175F4438-42DD-41E4-94C2-4F3B91C88904

Q33630579-293F9F71-5B7B-4C02-A677-19C9CD87139E

Q33630579-3303FF1A-5F6F-4022-A3FF-64C705A47490

Q33630579-383E6C75-7B4D-4B19-8EF7-91538C560B11

Q33630579-3A16C4EC-435B-4984-9E39-DE12858919DC

Q33630579-554CBA5C-B8BF-496A-8769-8773EB051936

P2860

Q33630579-140DC686-3A8C-4AE6-BDFD-546C03BD1A73

Q33630579-1AE3890C-61E3-4954-B979-5C01559F6B45

Q33630579-215680DF-AC49-461F-AEB2-5566DEC4FD36

Q33630579-26FF1FFB-6255-41A5-BD88-14F84F179DDC

Q33630579-2B91BD42-CD6A-4BDD-A815-03BDA91C9AA6

Q33630579-3629A3A2-07CA-4B47-90A8-D4826E14F7B3

Q33630579-421FCA07-EF8C-40B5-BCE7-DC72F9CBDEEB

Q33630579-51E66480-2879-482D-9C8B-B8B06CF47151

Q33630579-63BF63F5-FFB9-4B06-8203-F9F309763937

Q33630579-6DE1DD5A-38FC-46E8-84D7-0844BAC0EB00

P304

Q33630579-BD2EA103-91D5-42CE-B842-F93E57AB5B92

P31

Q33630579-1962FF51-488C-46A8-A7F1-370B5B2F5E11

P356

Q33630579-CE0FDF63-D5E9-4E2A-9102-0F78503C1E80

P433

Q33630579-1D0FE8D8-9485-41FC-9948-D4EBFFDE730B

P478

Q33630579-60FA10C6-1647-4CC5-A30A-315AD78FB8FE

P577

Q33630579-EAF460E3-CC98-4979-B112-62093C9F347E

P5875

Q33630579-1D1E1D7F-4D1F-4A63-A70B-BAA35E9A6468

P698

Q33630579-5D06745E-AF9D-445D-9E75-8D46C3D9CC61

P932

Q33630579-9318D3CE-205F-4933-8663-269AA866FB10

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Discovery of Phenylaminopyridi ...... erse Transcriptase Inhibitors.

@en

P2093

Changmin Park

http://www.w3.org/2001/XMLSchema#string

Doohyun Lee

http://www.w3.org/2001/XMLSchema#string

Hyoung Cheul Kim

http://www.w3.org/2001/XMLSchema#string

Inhee Choi

http://www.w3.org/2001/XMLSchema#string

Jaewan Yoon

http://www.w3.org/2001/XMLSchema#string

Jeongjin Kwon

http://www.w3.org/2001/XMLSchema#string

Jihyun Choi

http://www.w3.org/2001/XMLSchema#string

Jinhwa Lee

http://www.w3.org/2001/XMLSchema#string

Jiyoun Nam

http://www.w3.org/2001/XMLSchema#string

Jonathan Cechetto

http://www.w3.org/2001/XMLSchema#string

P2860

Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore

Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses

Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).

Medicinal chemistry of hERG optimizations: Highlights and hang-ups.

Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention.

Developments of indoles as anti-HIV-1 inhibitors.

Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.

Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?

P304

678-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML300146Q

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230719354

http://www.w3.org/2001/XMLSchema#string

P698

24900529

http://www.w3.org/2001/XMLSchema#string

P932

4025836

http://www.w3.org/2001/XMLSchema#string